Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12421280
Insulin like growth factor binding protein bioactive peptide fragments
granted -
US 12416006
Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereof
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12410442
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
granted -
US 12403164
Lentiviral vector formulations
granted -
US 12403183
Factor VIII polypeptide formulations
granted -
US 12398373
Enhanced immune effector cells and use thereof
granted -
US 12391642
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12383618
Expression vector delivery system and use thereof for inducing an immune response
granted -
US 12377068
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 12378558
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use
granted -
US 12371747
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
granted -
US 12365887
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 12364775
Viral vectors for cancer therapy
granted -
US 12338439
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
granted -
US 12331297
Coagulation factor V (F5) iRNA compositions and methods of use thereof
granted -
US 12331307
Modified immunization vectors
granted -
US 12324828
Conjugates of a factor VIII moiety having an oxime-containing linkage
granted -
US 12312616
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 12304969
Factor XI A2 domain-binding antibodies and methods of use thereof
granted -
US 12297186
Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5
granted -
US 12290505
Tissue factor-targeted antibody-drug conjugate
granted -
US 12285472
Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof
granted -
US 12275955
Combining iPSC derived effector cell types for immunotherapy use
granted